ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Weiwei Hu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5153594673. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2026: 1 paper

Papers 1

Discovery of a Novel Dual-Targeting KRAS G12D/HDAC Peptide Inhibitor for the Treatment of Pancreatic Cancer. Last author DOI 10.1021/acs.jmedchem.5c02435 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qiaoxuan Zhang · 1 shared paper, 2026 · strength 0.28
- Paper Discovery of a Novel Dual-Targeting KRAS G12D/HDAC Peptide Inhibitor for the Treatment of Pancreatic Cancer. DOI 10.1021/acs.jmedchem.5c02435 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.